Aranesp Injection, Solution
Product Images NDC 55513-032

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 44 technical images submitted to the FDA as part of the official labeling for Aranesp (NDC 55513-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

4. Gather The Other Supplies You Will Need For Your Injection (vial, Syringe, Alcohol Wipes, Cotton Ball, And A Puncture-proof Container For Throwing Away The Syringe And Needle). See Figure 1 (Aranesp 03)

FDA Label Image

6. Wash Your Hands Well With Soap And Water Before Preparing The Medicine. See Figure 2. (Aranesp 04)

FDA Label Image

7. Flip Off The Protective Color Cap On The Top Of The Vial. Do Not Remove The Grey Rubber Stopper. Wipe The Top Of The Grey Rubber Stopper With An Alcohol Wipe. See Figures 3 And 4. (Aranesp 05)

FDA Label Image
FDA Label Image

11. Push The Plunger Of The Syringe Down To Inject The Air From The Syringe Into The Vial Of Aranesp. The Air Injected Into The Vial Will Allow Aranesp To Be Easily Withdrawn Into The Syringe. See Figure 7. (Aranesp 07)

FDA Label Image

12. Keep The Needle Inside The Vial. Turn The Vial And Syringe Upside Down. Be Sure The Tip Of The Needle Is In The Aranesp Liquid. Keep The Vial Upside Down. Slowly Pull Back On The Plunger To Fill The Syringe With Aranesp Liquid To The Number (ml Or Cc) That Matches The Dose Your Healthcare Provider Prescribed. See Figure 8. (Aranesp 08)

FDA Label Image

13. Keep The Needle In The Vial. Check For Air Bubbles In The Syringe. A Small Amount Of Air Is Harmless. Too Large An Air Bubble Will Give You The Wrong Aranesp Dose. To Remove Air Bubbles, Gently Tap The Syringe With Your Fingers Until The Air Bubbles Rise To The Top Of The Syringe. Slowly Push The Plunger Up To Force The Air Bubbles Out Of The Syringe. Keep The Tip Of The Needle In The Aranesp Liquid. Pull The Plunger Back To The Number On The Syringe That Matches Your Dose. Check Again For Air Bubbles. If There Are Still Air Bubbles, Repeat The Steps Above To Remove Them. See Figures 9 And 10. (Aranesp 09)

FDA Label Image
FDA Label Image

Clean The Skin With An Alcohol Wipe Where The Injection Is To Be Made. Be Careful Not To Touch The Skin That Has Been Wiped Clean. See Figure 12. (Aranesp 0b)

FDA Label Image

Use The Other Hand To Pinch A Fold Of Skin At The Cleaned Injection Site. Do Not Touch The Cleaned Area Of Skin. See Figure 13. (Aranesp 0c)

FDA Label Image

Hold The Syringe Like You Would Hold A Pencil. Use A Quick “dart-like” Motion To Insert The Needle Either Straight Up And Down (90-degree Angle) Or At A Slight Angle (45 Degrees) Into The Skin. Inject The Prescribed Dose Subcutaneously As Directed By Your Doctor, Nurse, Or Pharmacist. See Figure 14. (Aranesp 0d)

FDA Label Image

Wipe Off The Venous Port Of The Hemodialysis Tubing With An Alcohol Wipe. See Figure 15. (Aranesp 0e)

FDA Label Image

• Insert The Needle Of The Syringe Into The Cleaned Venous Port And Push The Plunger All The Way Down To Inject All The Aranesp. See Figure 16. (Aranesp 0f)

FDA Label Image

Before Use And After Use (Aranesp 11)

FDA Label Image

Open The Package And Remove The Syringe From The Tray. Grab The Yellow Safety Guard To Remove The Prefilled Syringe From The Tray. (Aranesp 12)

FDA Label Image

B Inspect The Medicine And Prefilled Syringe. (Aranesp 13)

FDA Label Image

C Gather All Materials Needed For Your Injection. (Aranesp 14)

FDA Label Image

D Prepare And Clean Your Injection Site(s). (Aranesp 15)

D  Prepare And Clean Your Injection Site(s). (Aranesp 15)
This appears to be a list of body parts labeled as "Upper arm", "Stomach", "Buttocks", and "Thigh". It seems to be a possible categorization for body measurements or areas of interest in medical or fitness contexts.*
FDA Label Image

E Hold The Prefilled Syringe By The Syringe Barrel. Carefully Pull The Gray Needle Cap Straight Off And Away From Your Body. (Aranesp 16)

E  Hold The Prefilled Syringe By The Syringe Barrel.  Carefully Pull The Gray Needle Cap Straight Off And Away From Your Body. (Aranesp 16)
This text is a description of a product called "syringe barrel". It is likely that the product is a component of a syringe and may be the part that holds the medication or liquid being injected. No further details are available.*
FDA Label Image

Check Your Prescription Before You Inject Your Dose. (Aranesp 17)

Check Your Prescription Before You Inject Your Dose. (Aranesp 17)
Check your prescription before you inject your dose.*
FDA Label Image

G Point The Needle Up And Tap Gently Until The Air Rises To The Top. (Aranesp 18)

FDA Label Image

H Slowly Push The Plunger Rod Up To The Line On The Syringe Barrel That Matches Your Prescribed Dose. (Aranesp 19)

FDA Label Image

I Pinch Your Injection Site To Create A Firm Surface. (Aranesp 1a)

FDA Label Image

J Hold The Pinch. Insert The Needle Into The Skin At 45 To 90 Degrees. (Aranesp 1b)

FDA Label Image

When Done, Gently Pull The Syringe Off Of Your Skin, And Continue To Step 4: Finish. (Aranesp 1c)

FDA Label Image

Or (Aranesp 1d)

FDA Label Image

Before You Finish (Aranesp 1e)

FDA Label Image

For Your Safety, Pull The Yellow Safety Guard Until It Clicks And Covers The Needle. (Aranesp 1f)

FDA Label Image

M Discard (throw Away) The Used Prefilled Syringe. (Aranesp 20)

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Single-Dose Prefilled Syringes with 27 Gauge Needles of Aranesp® singleJect® are available in a dose of 10 mog/0.4 mL. It is a sterile solution without any preservative and should be stored at 2° to 8°C (36° to 46°F). It should not be frozen or shaken and protected from light. This product contains dry natural rubber. For intravenous or subcutaneous use only. The manufacturer is Amgen, which is located in Thousand Oaks, CA 91320-709 USA.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Aranesp® SingleJect® is a sterile solution that contains recombinant Abumin and is used intravenously or subcutaneously. The product should be stored at 2° to 8°C and should be protected from light. This product contains dry natural rubber. It is manufactured by Amgen in Thousand Oaks, CA.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
The text describes a pre-filled syringe containing a medication called Aranesp, with a 27 gauge needle, recommended for use via intravenous or subcutaneous injection. The medication is a recombinant Albumin Free solution containing 40mg/04mL and should be stored at 2° to 8°C (36° to 46°F), protected from light, and not to be frozen or shaken. The product contains dry natural rubber, and the manufacturer is Amgen.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
This is a description of a medication product called Aranesp SingleJect produced by AMGEN. It is a sterile solution intended for intravenous or subcutaneous use only. The solution comes in a single-dose prefilled syringe with a 27 gauge needle. The medication contains darbepoetin alfa in a recombinant albumin-free form. It has a concentration of 60mg/0.3mL and no preservatives. The product should be stored at a temperature range of 2°C to 8°C (36°F to 46°F) and protected from light. It is important to note that this product contains dry natural rubber.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
This is a description of Aranesp SingleJect, a prefilled syringe with a 27 gauge needle that contains 100 meg/0.5 mL of recombinant Albumin-free darbepoetin alfa, a medication used for intravenous or subcutaneous use only. It is a sterile solution with no preservative and should be stored between 2° to 8°C (36° to 46°F). The product should not be frozen or shaken and should be protected from light. The manufacturer is Amgen and it contains dry natural rubber.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
This is a product description for "SingleJect Aranesp" by Amgen, which is a sterile solution of recombinant Albumin Free darbepoetin alfa in a single-dose prefilled syringe with a 27-gauge needle. It is indicated for intravenous or subcutaneous use only, has no preservative, and should be stored at a temperature of 2°C to 8°C. The product should not be frozen or shaken and must be protected from light. The package contains dry natural rubber.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
This is a product description for a medication called "Aranesp® singleJect". It is manufactured by Amgen and contains 200 meg/0.4 mL of a recombinant drug. The medication is packaged in "Singe-Dooe Priled Synnge" with a 27 Gauge odls and is "AburinFree". There are storage instructions provided that include keeping the product away from light, freezing, and shaking. It is also noted that the product contains natural rubber.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
This is a description of a product called "AMGEN Arane". It is a recombinant AburinFroe and includes a caution against freezing or shaking, as well as a warning to protect it from light. The product contains natural rubber. It was manufactured by Amgen in Thousand Oaks, USA.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
The text seems to be a label or package insert for a medication manufactured by the company AMGEN called "Aranesp.” The medication is stored at a temperature of 2-8°C and should be protected from light. There is a warning that the product may contain natural rubber. The rest of the text is not clear and contains typographical errors and missing words.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
This is a description of a medicine product called "Single-Dose Vials" manufactured by AMGEN. The medicine is a recombinant Aburin free solution used for intravenous or subcutaneous injection. It comes in a single-dose vial that contains 40 meg/t mL of the medicine. The solution is sterile and has no preservatives. It should be stored at a temperature of 2° to 8°C (36° to 46°F) and protected from light. Shake and freezing should be avoided. The text also includes some manufacturer's information and copyright notices.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
This is a description of a medication called Aranesp manufactured by Amgen. It is a recombinant Albumin-Free medication administered either intravenously or subcutaneously. The medication comes in 100 mg/1mL dose and is contained in single-dose vials. The medication should be stored at 3-8 degrees Celsius and should not be frozen or shaken. The medication is only available on prescription. The text also contains a lot of random characters and words that were not recognized by the .*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
Single-dose vial of Darbepoetin Alfa, a medication used for intravenous or subcutaneous use only, with a concentration of 200mg/1mL in an albumin-free solution. The vial contains 1200 mega units and is meant for single use.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.